Updated:
Remedi SeniorCare
Remedi SeniorCare provides long-term care pharmacy services, operating the Paxit unit-dose medication system across 10 US locations.
Remedi SeniorCare
Remedi SeniorCare provides pharmacy services to skilled nursing facilities, assisted living communities, and other adult congregate living environments across the United States. The company operates as a specialty pharmacy, distinct from retail chains, and focuses on medication management within institutional settings. Remedi’s core offering is the Paxit 24-hour unit-dose system, which individually wraps and labels each dose, eliminating commingling. The firm claims the system reduces touchpoints and infection risk while improving verification through a six-point process. Services span medication dispensing, administrative cost tools, and 24/7 pharmacist support. Remedi also runs educational programs, including bi-monthly newsletters, in-service sessions, and CEU courses. The company lists 10 pharmacy locations: Baltimore (corporate), Charlotte, Cleveland, Dallas, Dayton, Denver, Oklahoma City, Plymouth (MI), Richmond, and Tampa. It serves facilities across all 50 states, as indicated by its contact form. The total number of employees or facilities served is not disclosed. Remedi’s structural differentiator lies in its dedicated long-term care focus and proprietary Paxit packaging technology. Unlike general retail or mail-order pharmacies, Remedi builds its operations around the specific workflows and safety requirements of nursing homes and assisted living centers, embedding clinical consultants directly with facility staff.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Baltimore
Corporate office
Baltimore, MD, United States
Additional offices
Charlotte, NC · Cleveland, OH · Dallas, TX · Dayton, OH · Denver, CO · Oklahoma City, OK · Plymouth, MI · Richmond, VA · Tampa, FL
Sector focus
Frequently asked questions
Who runs investment decisions at Remedi SeniorCare?
Remedi SeniorCare does not publicly disclose a management team or ownership structure. The firm's website lists no named executives or investment principals.
How does Remedi SeniorCare source proprietary deal flow?
Remedi SeniorCare operates as a pharmacy services provider, not an investment vehicle. It does not describe any proprietary deal sourcing for external capital deployment.
Is Remedi SeniorCare structured as a single family office or does it operate more like a venture firm?
Remedi SeniorCare's website describes it as a pharmacy services company serving long-term care facilities. It does not identify as a family office, investment firm, or venture capital entity.
What investment stages does Remedi SeniorCare typically target?
Remedi SeniorCare does not disclose any investment stage or portfolio. Its public materials focus on pharmacy operations and medication management, not capital deployment.
Which sectors does Remedi SeniorCare explicitly avoid?
Remedi SeniorCare does not publish any investment exclusions. Its stated focus is limited to long-term care pharmacy services.
How is Remedi SeniorCare related to parent or related entities?
Remedi SeniorCare's website lists partners (the logos are not identifiable from the scraped content) but does not disclose ownership or parent corporate relationships.
Where does the underlying wealth come from?
Remedi SeniorCare does not disclose any underlying wealth or funding sources. The firm's literature describes it as a pharmacy service provider, not a managed pool of capital.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: